Merck KGaA
MRK: XETR (DEU)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|@k | LOCK|&%fp$ | LOCK|#!<D^^Z |
Merck KGaA Earnings: Overall Strong Performance and Guidance Confirmed; Shares Undervalued
Merck KGaA reported third-quarter earnings with 5.2% organic sales growth, and the adjusted EBITDA margin increased by 70 basis points to 31.4%. Management confirmed its full-year outlook, while narrowing the ranges to approximately 3% organic sales growth and 5%-7% adjusted EBITDA growth.
